摘要
流感是一种由流感病毒引起的传染性呼吸道疾病。老年人、婴幼儿和患有基础疾病人群,出现严重临床症状和并发症的风险更高。新型冠状病毒与流感病毒的共同感染和流行可导致新型冠状病毒肺炎的预防、诊断、控制、治疗和康复复杂化。季节性流感疫苗和新型冠状病毒肺炎疫苗在目标人群、接种时间、接种单位都有重叠,虽然目前流感疫苗与新型冠状病毒肺炎疫苗同时接种免疫原性和安全性的相关研究证据不足,但世界卫生组织和一些国家已建议流感灭活疫苗和新型冠状病毒肺炎疫苗同时接种。本文汇总了国内外两种疫苗同时接种的政策和研究进展,同时提出了相应的思考和建议,以期为季节性流感疫苗和新型冠状病毒肺炎疫苗接种策略的制订提供科学支撑。
Influenza is an infectious respiratory disease caused by the influenza viruses.Older people,infants and people with underlying medical conditions could have a higher risk of severe influenza symptoms and complications.The co-infection of Coronavirus Diseases 2019(COVID-19)with influenza viruses could lead to the complication of prevention,diagnosis,control,treatment,and recovery of COVID-19.Influenza vaccine and COVID-19 vaccine overlapped in target populations,vaccination time,and inoculation units.Although there was insufficient evidence on the immunogenicity and safety of co-administration of influenza vaccine and COVID-19 vaccine,World Health Organization and some countries recommended co-administration of inactivated influenza vaccine and COVID-19 vaccine.This review summarized domestic and international vaccination policies and research progress,and put forward corresponding suggestions in order to provide scientific support for the formulation of vaccination strategy on seasonal influenza vaccine and COVID-19 vaccine.
作者
张婷
白雪飞
王雯
刘晓雪
张习习
王大燕
张少白
陈直平
何寒青
黄卓英
徐爱强
彭质斌
冯录召
余文周
冯子健
Zhang Ting;Bai Xuefei;Wang Wen;Liu Xiaoxue;Zhang Xixi;Wang Dayan;Zhang Shaobai;Chen Zhiping;He Hanqing;Huang Zhuoying;Xu Aiqiang;Peng Zhibin;Feng Luzhao;Yu Wenzhou;Feng Zijian(School of Population Medicine and Public Health,Chinese Academy of Medical Sciences&Peking Union Medical College Beijing 100730,China;Institute of Public Health Service Information,Sichuan Center for Disease Control and Prevention,Chengdu 610041,China;Department of Immunization Planning,Guangzhou Center for Disease Control and Prevention,Guangzhou 510440,China;Department of Expanded Program of Immunization,Jinan Center for Disease Control and Prevention,Jinan 250021,China;National Immunization Program,Chinese Center for Disease Control and Prevention,Beijing 100050,China;National Institute for Viral Disease Control and Prevention,Chinese Center for Disease Control and Prevention,Beijing 102206,China;Shaanxi Province Center for Disease Control and Prevention,Xi'an 710054,China;Zhejiang Center for Disease Control and Prevention,Hangzhou 310051,China;Department of Immunization,Zhejiang Center for Disease Control and Prevention,Hangzhou 310051,China;Department of Immunization Program,Shanghai Municipal Center for Disease Control and Prevention,Shanghai 200336,China;Shandong Provincial Center for Disease Control and Prevention,Jinan 250014,China;Division of Infectious Diseases,Chinese Center for Disease Control and Prevention,Beijing 102206,China;Chinese Preventive Medicine Association,Beijing 100021,China)
出处
《中华预防医学杂志》
CAS
CSCD
北大核心
2022年第2期103-107,共5页
Chinese Journal of Preventive Medicine